Related Experiment Videos
Neutron radiobiology revisited
1CRC Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, England.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1994
Summary
This review finds that high-energy neutrons offer little therapeutic advantage over conventional radiation for tumors, especially slow-growing ones. Current research focuses on multifactorial approaches to enhance radiation therapy effectiveness.
Area of Science:
- Radiobiology
- Radiation Oncology
- Medical Physics
Background:
- Relative biological effectiveness (RBE) of radiation varies with dose per fraction.
- Late-responding normal tissues show steeper RBE increases at low doses compared to acute reactions.
- Tumor RBE is complex due to factors like hypoxia, reoxygenation, and DNA repair capacity.
Purpose of the Study:
- To review experimental data on normal tissue and tumor responses to radiation.
- To compare RBE values between tumors and normal tissues.
- To discuss the limited therapeutic advantage of neutrons and explore alternative strategies.
Main Methods:
- Review of experimental results from animal studies on normal tissues and tumors.
- Analysis of dose per fraction dependence of RBE.
- Comparison of RBE values for different tumor types and normal tissues.
Main Results:
- Normal tissue RBE shows dose per fraction dependence, with a steeper increase for late effects at low doses.
- Tumor RBE is complex, influenced by hypoxia, reoxygenation, and repair.
- Experimental evidence for a therapeutic advantage of neutrons at clinical doses is limited, particularly for slow-growing tumors.
Conclusions:
- Neutrons show limited clinical benefit due to complex dose-response relationships in tumors.
- Alternative strategies like hyperfractionation and radiosensitizers are promising for overcoming radiation resistance.
- Further research is needed to optimize radiation therapy for improved tumor control and reduced normal tissue toxicity.